Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hybridization-Driven Herbivorous Adaptation in Fish: Morphological, Digestive, Transcriptome, and Microbial Evidence from a Hybrid of <i>Megalobrama amblycephala</i> (♀) × <i>Culter mongolicus</i> (♂).

International journal of molecular sciences·2026
Same author

The mitochondrial DnaJA protein LMA1 regulates reactive oxygen species homeostasis and anthocyanin biosynthesis in <i>Medicago truncatula</i>.

Plant diversity·2026
Same author

Rap1b promotes glioma growth and stemness via regulation of Notch1 and VEGFR2 signaling pathways.

Cellular signalling·2026
Same author

Dual Function Characterisation of the 4-Cysteine Hepcidin in the Antarctic Toothfish Dissostichus mawsoni.

Journal of fish diseases·2026
Same author

Dynamics and Health Risks of Fungal Bioaerosols in Confined Broiler Houses During Winter.

Animals : an open access journal from MDPI·2026
Same author

Lignin degradation, metabolic profiling, and cold adaptation of <i>Psychrobacter</i> strain CLB018 isolated from the Antarctic fish <i>Trematomus bernacchii</i>.

3 Biotech·2026
Same journal

Correction: Adeluola et al. Chemoprevention of 4-NQO-Induced Oral Cancer by the Combination of Resveratrol and EGCG: In Vivo, In Silico and In Vitro Studies. <i>Cancers</i> 2026, <i>18</i>, 1098.

Cancers·2026
Same journal

Correction: Peñalver et al. Guidelines for Diagnosis, Treatment, and Follow-Up of Patients with Follicular Lymphoma-Spanish Lymphoma Group (GELTAMO) 2026. <i>Cancers</i> 2026, <i>18</i>, 395.

Cancers·2026
Same journal

Correction: Accorsi Buttini et al. Development of a Simplified Geriatric Score-4 (SGS-4) to Predict Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged over 50. <i>Cancers</i> 2025, <i>17</i>, 3278.

Cancers·2026
Same journal

Age-Stratified Long-Term Outcomes of Immune Checkpoint Inhibitors for Stage IV Melanoma and NSCLC in The Netherlands: A Population-Based Study.

Cancers·2026
Same journal

Targeting Ferroptosis in Glioblastoma: Molecular Mechanisms, Tumor Microenvironment, and Therapeutic Opportunities.

Cancers·2026
Same journal

Neoadjuvant Immunotherapy-Based Treatment Versus Chemotherapy Alone in Resectable Locally Advanced dMMR/MSI-H Gastric Cancer: A Real-World Study with Meta-Analysis.

Cancers·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2025

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

15.3K

Progress in Glioma Stem Cell Research.

Vanajothi Ramar1, Shanchun Guo2, BreAnna Hudson1

  • 1Department of Microbiology, Biochemistry & Immunology, Morehouse School of Medicine, Atlanta, GA 30310, USA.

Cancers
|January 11, 2024
PubMed
Summary
This summary is machine-generated.

Glioblastoma multiforme (GBM) is a challenging brain tumor resistant to current treatments. This review explores glioma stem cell biology and targeted therapies to improve GBM patient outcomes.

Keywords:
GSCsNF-κBTMZdrug targetsglioblastomamolecular mechanism

More Related Videos

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.3K
Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.1K

Related Experiment Videos

Last Updated: Jul 6, 2025

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry
12:25

Optimization of High Grade Glioma Cell Culture from Surgical Specimens for Use in Clinically Relevant Animal Models and 3D Immunochemistry

Published on: January 7, 2014

15.3K
Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion
09:36

Live-Cell Imaging Assays to Study Glioblastoma Brain Tumor Stem Cell Migration and Invasion

Published on: August 29, 2018

10.3K
Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window
09:44

Imaging Glioma Initiation In Vivo Through a Polished and Reinforced Thin-skull Cranial Window

Published on: November 20, 2012

13.1K

Area of Science:

  • Neuro-oncology
  • Cancer Biology
  • Molecular Medicine

Background:

  • Glioblastoma multiforme (GBM) is an aggressive primary brain tumor with poor prognosis.
  • Standard treatments (surgery, radiation, temozolomide chemotherapy) show limited efficacy due to factors like the blood-brain barrier and tumor heterogeneity.
  • Glioma stem cells (GSCs) are implicated in GBM recurrence and treatment resistance.

Purpose of the Study:

  • To review current knowledge on glioma stem cell (GSC) biology.
  • To explore molecular mechanisms and signaling pathways associated with GSCs.
  • To discuss emerging therapeutic strategies targeting GSCs in GBM.

Main Methods:

  • Literature review of GSC biology, molecular mechanisms, and signaling pathways.
  • Analysis of metabolic reprogramming in GSCs.
  • Evaluation of current and potential therapeutic targets and inhibitors for GSCs.

Main Results:

  • GSCs exhibit unique biological properties contributing to GBM's aggressive nature.
  • Key signaling pathways (EGFR, PI3K/AKT/mTOR, HGFR/c-MET, NF-κB, Wnt, Notch, STAT3) are crucial for GSC maintenance and function.
  • GSCs display metabolic reprogramming, notably enhanced glycolysis and aldehyde dehydrogenase activity.

Conclusions:

  • Targeting GSCs represents a promising strategy to overcome GBM resistance and improve patient outcomes.
  • Understanding GSC-specific pathways and metabolic vulnerabilities is critical for developing novel therapies.
  • Further research into GSC biology and targeted inhibitors is essential for advancing GBM treatment.